Da Hee Han

PharmD

Most Recent Articles by Da Hee Han

Caplacizumab Cuts Time to Platelet Count Normalization in aTTP Patients

Caplacizumab Cuts Time to Platelet Count Normalization in aTTP Patients

By

The HERCULES (NCT02553317) study included 145 patients with aTTP who were randomized to receive either caplacizumab 10mg or placebo in conjunction with plasma exchange and immunosuppression.

FDA to Review Tafamidis for Treatment of Transthyretin Amyloid Cardiomyopathy

FDA to Review Tafamidis for Treatment of Transthyretin Amyloid Cardiomyopathy

By

Tafamidis is an oral small molecule candidate that selectively binds at specific sites on the transthyretin tetramer to prevent destabilization of the transthyretin transport protein and formation of amyloid that causes ATTR-CM.

Glass Particulate Identified in Certain Vials of Vecuronium Bromide

Glass Particulate Identified in Certain Vials of Vecuronium Bromide

By

Vecuronium Bromide, a neuromuscular blocker, is indicated as adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

reSET-O Digital Therapeutic for Opioid Use Disorder Now Available

reSET-O Digital Therapeutic for Opioid Use Disorder Now Available

By

Sandoz and Pear Therapeutics announced the launch of reSET-O, a new digital therapeutic for patients aged ≥18 years with opioid use disorder (OUD) currently under clinician care.

FDA-Approved Wearable Blood Pressure Monitor Now Available

FDA-Approved Wearable Blood Pressure Monitor Now Available

By

HeartGuide is designed as a wrist watch that uses the oscillometric cuff method, the standard for medical-grade personal blood pressure measurement.

More Articles by Da Hee Han

Free E-Newsletter